All analyzed pilot group RMS tumour tissue expressed BARD1 FL and BARD1 β (n = 7/7; 100%), while in adjacent tissue, one did not express BARD1 FL, and two did not express BARD1 β (n = 5/7; 71%). The gene discussed is BARD1; the disease is neoplasm.